+ 33 1 46 99 68 20

 

A portfolio of essential medicines

Teralithe®

Dosages and presentations

TERALITHE® 250mg. Scored tablet. Box of 100 tablets.
THERALITE® 300mg. Tablets. Box of 50 tablets. (Colombia only).
TERALITHE® LP 400mg. Extended-release scored tablet. Box of 60 tablets.
p

Product information - Patient information leaflet

Active ingredient

Lithium carbonate

Marketing

  • France
  • Colombia (THERALITE® 300mg only)
  • Morocco (TERALITHE® 250mg only). MA holder: Maphar
  • Tunisia (TERALITHE® 250mg only)

Product news

Product available
Packaging may differ from country to country

This information is intended for healthcare professionals.

Our therapeutic areas

and our main products

Infectiology

Amikacin

Aztreonam

Amoxicillin

Xyllomac®

(France)

Delamoxyle®

(Belgium - Luxembourg)

Delamoxyl®

(Switzerland)

Amoxicillin and clavulanic acid

Benzathine benzylpenicillin

Extencilline®

(France - Switzerland)

Extencin®

(Netherlands)

Benzylpenicillin benzathine

(United Kingdom)

Oxacillin

Istopen®

(France)

Penstapho®

(Italy)

Prostaphlin®

(Czech Republic)

Central nervous system

Lithium carbonate
Tropatépine hydrochloride
Pipotiazine palmitic ester
Lorazepam

Other

Histamine dihydrochloride
Pipobroman
N-acetylcysteine
Some of our products may be available internationally through our distributors, under different trade names. Please contact us to find out more.

REQUEST MEDICAL INFORMATION - REPORT AN ADVERSE EVENT

To request medical information on Delbert Pharma products or report an adverse event,
please write to pharmacovigilance@delbert.fr or contact us on + 33 1 46 99 68 20.

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.